CHIEF DEV. OFFICER · MeiraGTx Holdings plc · MeiraGTx Holdings plc — Restricted Share Units
Option exercise — administrative, little informational value
No reported dollar value · new position
Disclosed 1 business day after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Giroux RichardCFO & COO | Open-market sale · 10b5-1 plan | SELL | $557K 56.0K sh | Oct 20, 2026 traded Oct 20, 2026 | |
| 12 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $294K 27.7K sh | Oct 6, 2026 traded Oct 6, 2026 | |
| 1 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $35K 2,547 sh | Jul 7, 2026 traded Jul 7, 2026 | |
| 7 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $374K 25.1K sh | Jul 7, 2026 traded Jul 7, 2026 | |
| 5 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Grant or award | A | — 70.0K sh | Jun 29, 2026 traded Jun 25, 2026 | |
| 5 | Giroux RichardCFO & COO | Grant or award | A | — 980.0K sh | Jun 29, 2026 traded Jun 25, 2026 | |
| 9 | Forbes AlexandriaDirector, PRESIDENT & CEO | Grant or award | A | — 980.0K sh | Jun 29, 2026 traded Jun 25, 2026 | |
| 9 | Zeldin Robert KCHIEF MEDICAL OFFICER | Grant or award | A | — 100.0K sh | Jun 29, 2026 traded Jun 25, 2026 | |
| 9 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Grant or award | A | — 100.0K sh | Jun 29, 2026 traded Jun 25, 2026 | |
| 9 | Yu DebraDirector | Grant or award | A | — 60.0K sh | Jun 15, 2026 traded Jun 11, 2026 | |
| 21 | Harris Keith R.Director | Option exercise | M | — 75.0K sh | Jun 10, 2026 traded Jun 10, 2026 | |
| 9 | Harris Keith R.Director | Option exercise | M | — 75.0K sh | Jun 10, 2026 traded Jun 10, 2026 | |
| 9 | Fleck Penny ReneeCHIEF DEVELOPMENT OFFICER | Grant or award | A | — 100.0K sh | May 14, 2026 traded May 13, 2026 | |
| 9 | Fleck Penny ReneeCHIEF DEVELOPMENT OFFICER | Grant or award | A | — 100.0K sh | May 14, 2026 traded May 13, 2026 | |
| 20 | Giroux RichardCFO & COO | Open-market sale · 10b5-1 plan | SELL | $572K 56.0K sh | Apr 21, 2026 traded Apr 21, 2026 | |
| 16 | Naylor StuartCHIEF DEV. OFFICER | Open-market sale · 10b5-1 plan | SELL | $259K 27.7K sh | Apr 7, 2026 traded Apr 7, 2026 | |
| 30 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $202K 27.2K sh | Jan 21, 2026 traded Jan 17, 2026 | |
| 27 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 50.0K sh | Jan 21, 2026 traded Jan 17, 2026 | |
| 15 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 50.0K sh | Jan 21, 2026 traded Jan 17, 2026 | |
| 13 | Giroux RichardCFO & COO | Option exercise | M | — 52.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Naylor Stuart filed this Form 4 reporting a option exercise of MGTX on Jan 7, 2026. It became public on Jan 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.